Lanean...
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis
The clinical efficacy of B cell targeting therapies highlights the pathogenic potential of B cells in inflammatory diseases. Expression of Fc Receptor like 4 (FcRL4) identifies a memory B cell subset, which is enriched in the joints of patients with rheumatoid arthritis (RA) and in mucosa-associated...
Gorde:
Argitaratua izan da: | J Autoimmun |
---|---|
Egile Nagusiak: | , , , , , , , , , , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Academic Press
2017
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473332/ https://ncbi.nlm.nih.gov/pubmed/28343748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2017.03.004 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|